Evaluation of Retrospective Patient Preference on Extent of Resection of Nonfunctioning Pituitary Adenomas

Behzadi, Faraz; Ruiz, Gianna M.; Tran, Dana H.; Schaible, Peter A.; Allen, Matthew B.; Germanwala, Anand V.

doi:10.1016/j.wneu.2023.11.053

Cited by 4 publications

(1 citation statement)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We have previously described that many patients with adenomas and intact pituitary function prefer to avoid steroid replacement therapy at the cost of a subtotal resection. [16] Accordingly, we hold a preoperative conversation with patients to discuss surgical strategies and anticipated outcomes thereof; intraoperative decisions are then guided by the pathology observed along with patients' expressed preferences.…”

Section: Discussionmentioning

confidence: 99%

Endoscopic Endonasal Approach for Residual and Recurrent Craniopharyngioma after Transcranial Approach: A Multi-institutional Experience

Jani,

Raju,

Kim

et al. 2024

J Neurol Surg B Skull Base

Self Cite

View full text Add to dashboard Cite

Objectives: While the endoscopic endonasal approach (EEA) has become a well-established surgery for resection of craniopharyngiomas (CP), the utility of this procedure following subtotal resection from open transcranial approach (TCA) surgery has yet to be explored. Here we present a multi-institutional case series of patients who underwent EEA for treatment of recurrent CP originally treated by TCA, demonstrating the viability of this approach as salvage surgery. Design: Retrospective cohort Setting: Loyola University Medical Center and University of Pittsburgh Medical Center Participants: Patients who underwent EEA for recurrent CP following an initial TCA between 2003 and 2018. Main Outcome Measures: GTR rate, surgical complications, visual outcomes, and endocrine outcomes Results: Patients who underwent EEA for recurrent CP following a prior TCA had a GTR rate of 77%. EEA reoperation was not associated with worsening of visual outcomes as compared to the primary TCA (0% visual worsening after EEA reoperation vs. 40% after primary TCA, p=0.055). While primary TCA resulted in worsening endocrinopathies in 100% of patients (including 7 patients with permanent diabetes insipidus), subsequent EEA for re-resection of CP resulted in stable (30.8%) or improved (69.2%) endocrine function in all patients (p<0.001). Conclusions: EEA achieves reasonable GTR rates and is an effective, safe surgical option for recurrent CP post initial TCA. This approach demonstrated stable or improved visual and endocrinologic outcomes in all patients within our two-institution series. Thus, EEA should be considered as an efficacious form of re-treatment in cases of progressive and recurrent CP.

show abstract

Section: Discussionmentioning

confidence: 99%